Atlas Trials

Viral Oncoprotein Targeted Autologous T Cell Therapy for Merkel Cell Carcinoma

Clinical trial NCT01758458 · TERMINATED

Trial details

NCT number
NCT01758458
Sponsor
Fred Hutchinson Cancer Center
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Recurrent Merkel Cell CarcinomaStage IV Merkel Cell Carcinoma
Start date
2013-02-01
Primary completion
2016-05-01
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.